Draft legislation on violence against emergency workers to include community pharmacy teams

Draft legislation on violence against emergency workers to include community pharmacy teams

November 21 2017 A private member’s bill seeking to address violence against emergency...

Draft Order which will decriminalise dispensing errors is tabled

Draft Order which will decriminalise dispensing errors is tabled

November 16 2017 The regulatory changes which will decriminalise dispensing errors have been laid...

A better self-care programme is need before delisting OTC products from NHS prescriptions

A better self-care programme is need before delisting OTC products from NHS prescriptions

October 24 2017 The government should further empower the public to self-care before preventing...

PDA critical of GPhC proposals for standards for pharmacy premises

PDA critical of GPhC proposals for standards for pharmacy premises

October 23 2017 The Pharmacists’ Defence Association has warned that the pharmacy regulator...

ICO announces further resources for small businesses over GDPR compliance

ICO announces further resources for small businesses over GDPR compliance

October 23 2017 The Information Commissioner’s Office has announced it will set up a...

  • Draft legislation on violence against emergency workers to include community pharmacy teams

    Draft legislation on violence against emergency workers to include community pharmacy teams

    Tuesday, 21 November 2017 14:30
  • Draft Order which will decriminalise dispensing errors is tabled

    Draft Order which will decriminalise dispensing errors is tabled

    Thursday, 16 November 2017 18:09
  • A better self-care programme is need before delisting OTC products from NHS prescriptions

    A better self-care programme is need before delisting OTC products from NHS prescriptions

    Tuesday, 24 October 2017 14:53
  • PDA critical of GPhC proposals for standards for pharmacy premises

    PDA critical of GPhC proposals for standards for pharmacy premises

    Monday, 23 October 2017 09:30
  • ICO announces further resources for small businesses over GDPR compliance

    ICO announces further resources for small businesses over GDPR compliance

    Monday, 23 October 2017 09:02

Umesh Modi is a chartered accountant, and Pamini Jatheeskumar is a chartered certified accountant at Silver Levene...
  Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead...
Don Lavoie is alcohol programme manager at Public Health England and Gul Root is lead pharmacist, Health and Wellbeing Directorate, Public Health England
More inWhite Papers  

pills4June 27 2016

Guidance on naloxone supply has been updated with advice about what to consider when there is a need for use in people under 18 years.

The guidelines were introduced in October 2015 as part of a move to widen the availability of naloxone as an emergency antidote for overdoses caused by heroin and other opiates or opioids such as methadone and morphine.

They are intended for use by drug treatment services authorised to supply naloxone, including:

  • drug services commissioned from primary care providers
  • drug services commissioned from secondary care providers (including a range of specialised community and inpatient drug services)
  • commissioned services providing needle and syringe programmes (including those provided from pharmacies)
  • pharmacies providing drug treatment services.

The update says that “any drug treatment service considering providing a child or young person under 18 with training on overdose management or on the use of naloxone, or considering direct supply of naloxone, should always act in line with established clinical principles for the treatment of children and young people.

“This is the case whether the goal of such consideration is to reduce risks to a young person who is using drugs or to reduce risk for others (such as an opioid-using parent).”

It points out that there are no legal restrictions under the 2015 legislation, and that “such a decision would need very careful consideration and oversight and would need to be made on a case by case basis.

“An appropriately competent professional acting within a suitable clinical governance framework would have to consider the needs of each child or young person, taking account of potential benefits to the child of the intervention and any risks.”

Factors they would need to take into account include the child or young person’s ability to understand the issues involved and to provide suitable consent. “In the case of a child who exercises a carer role for a drug-using parent, consideration of the interests of the child can be quite complex.” There is also a need to consider issues such as those relating to child safeguarding.

Links:

Department of Health Guidance

Updated guidance

Legal & Policy News

November 22 2017 The public and health professionals are being asked to consider reporting side effects from over the counter medicines via the Yellow Card scheme.
December 7 2015 Pharmacists in Scotland have been asked to share their views on what politicians need to be made aware of ahead of the Scottish Parliament elections in 2016. The Royal Pharmaceutical Society...